Journals / Türkiye Çocuk Hastalıkları Dergisi / 2019 / Cilt: 13 - Sayı: 5

Is the Phototherapy Requirement in Neonatal Hyperbilirubinemia due to AB0 Incompatibility Predictable?

AB0 Uygunsuzluğuna Bağlı Hiperbilirubinemili Yenidoğanlarda Fototerapi Gereksinimi Öngörülebilir mi?

Pages
330–334
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It was concluded that Hgb, DAT and LDH values in the first 24 hours of life in the newborns with IHB due to AB0 incompatibility were not predictive for the phototherapy requirement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to investigate whether there is any predictive marker on the first day for the prediction of infants requiring phototherapy due to AB0 incompatibility associated neonatal hyperbilirubinemia.
📊
Key Findings & Data:Material and Methods: Full term healthy newborns with AB0 incompatibility were included.
💡
Conclusion & Impact:Conclusion: It was concluded that Hgb, DAT and LDH values in the first 24 hours of life in the newborns with IHB due to AB0 incompatibility were not predictive for the phototherapy requirement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to investigate whether there is any predictive marker on the first day for the prediction of infants requiring phototherapy due to AB0 incompatibility associated neonatal hyperbilirubinemia. Material and Methods: Full term healthy newborns with AB0 incompatibility were included. Hemoglobin (Hgb), bilirubin, and lactate dehydrogenase (LDH) values were recorded at the first 6th and 24th hours of the infants. The infants were monitored according to the Bhutani nomogram during the first 15 days. The infants who were applied phototherapy due to indirect hyperbilirubinemia (IHB) were recorded. We compared the infants who received and did not receive phototherapy. Results: Among 83 term newborns with AB0 incompatibility, there were 18 infants with B0 (21.6%) and 65 infants (78.3%) with A0 incompatibility. The direct antiglobin test (DAT) was positive in 44 (53%) infants. There were 13 DAT positive (33.3%) and 12 DAT negative (27.3%) infants treated with phototherapy due to IHB. There was no significant difference in the incidence of hospitalization between the two groups (p=0.58). There was no significant difference between the first 6th and 24th hour Hgb and LDH levels between the groups (p>0.05). However, bilirubin levels at the 24th hour of life were found to be higher in the infants that received phototherapy (p=0.03). Conclusion: It was concluded that Hgb, DAT and LDH values in the first 24 hours of life in the newborns with IHB due to AB0 incompatibility were not predictive for the phototherapy requirement. However, bilirubin levels at the 24th hour of life could be valuable. We considered that close follow-up of newborns with AB0 incompatibility could be appropriate due to the broad spectrum of the disease.

Özet

Amaç: Çalışmada, AB0 uygunsuzluğuna bağlı indirekt hiperbilirubinemi (İHB) gelişen yenidoğanlarda, fototerapi gereksinimini ilk gün saptayabilecek belirteçler araştırıldı.Gereç ve Yöntemler: Anne-bebek arasında AB0 uygunsuzluğu olan, zamanında doğmuş, ek hastalığı olmayan sağlıklıyenidoğanlar ileriye dönük izlem amacıyla çalışmaya alındı. Olguların ilk 6. ve 24. saatlerinde hemoglobin (Hgb), bilirubinve laktat dehidrogenaz (LDH) düzeylerine bakıldı. Olguların ilk 15 gün Bhutani nomogramına uygun sıklıkta serum bilirubin düzeyleri takip edildi ve fototerapi gereksinimi Amerikan Pediatri Akademisi’nin önerdiği sınırlar kullanılarak belirlendi.Fototerapi sınırını geçerek fototerapi uygulanan bebeklerle, fototerapi sınırının altında kalanların sonuçları karşılaştırıldı.Bulgular: AB0 uygunsuzluğu nedeniyle çalışmaya alınan 83 bebekten 18’inde B0 (%21.7), 65’inde (%78.3) A0 uygunsuzluğu saptandı. Bebeklerin 44’ünde (%53) direkt antiglobulin testi (DAT) pozitifti. DAT pozitif olan yenidoğanların13’ü (%33.3), DAT negatif olanların ise 12’si (%27.3) izlemde İHB nedeniyle fototerapi aldı. İki grup arasında yatış sıklığıaçısından anlamlı fark yoktu (p=0.58).İndirekt hiperbilirubinemi nedeniyle fototerapi uygulanan ve uygulanmayan gruplar arasında 6. ve 24. saat Hgb ile LDHdüzeyleri arasında anlamlı fark saptanmadı (p>0.05). Ancak, fototerapi gereksinimi olan hiperbilirubinemili bebeklerde24. saat bilirubin düzeyleri, fototerapi ihtiyacı olmayanlara göre daha yüksek bulundu (p=0.03).Sonuç: Yenidoğanlarda AB0 uygunsuzluğuna bağlı İHB nedeniyle fototerapi gereksiniminin belirlenmesinde, 24. saatHgb, DAT ve LDH düzeylerinin prediktif değeri yoktur, ancak 24. saat bilirubin düzeyi prediktif olabilir. AB0 uygunsuzluğuna bağlı hemolitik hastalık spektrumunun geniş olması nedeniyle, AB0 uygunsuzluğu olan yenidoğanların yakınizlenmeleri gerektiği düşünülmüştür.

🔖

Cite This Article

KIŞLAL, F. M., ALTUNTAŞ, N., TEKGÜNDÜZ, S. A., KIRGIN, B. Ö., DOĞAN, Ö. C. (2022). Is the Phototherapy Requirement in Neonatal Hyperbilirubinemia due to AB0 Incompatibility Predictable?. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 13 - Sayı: 5, 330–334. https://ajindex.com/articles/627160

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Yaseen H, Khalaf M, Rashid N, Darwich M. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with AB0 incompatibility and positive Coombs’ test? J Perinatol 2005;25:590-4
  2. Sarici SU, Yurdakök M, Serdar MA, Oran O, Erdem G, Tekinalp G, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe AB0 hemolytic disease in a selective high-risk population of newborns with AB0 incompatibility. Pediatrics 2002;109:e53
  3. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006;12:587-90
  4. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316
  5. Clifford JH, Mathews P, Reiquam CW, Palmer HD. Screening for hemolytic disease of the newborn by cord blood Coomb testing: Analysis of a five-year experience. Clin Pediatrics 1968;7:465-9
  6. Alter AA, Feldman F, Twersky J, De Vos E, Prutting DL, Miotti A, et al. Direct antiglobulin test in AB0 hemolytic disease of the newborn. Obstet Gynec 1969;33:846-51
  7. Orzalesi M, Gloria F, Lucarelli P, Bottini E. AB0 system incompatibility: Relationship between direct Coombs test positivity and neonatal jaundice. Pediatrics 1973;51:288-9
  8. Risemberg HM, Mazzi E, Macdonald MG, Peralta M, Heldrich F. Correlation of cord blood bilirubin levels with hyperbilirubinaemia in AB0 incompatibility. Arch Dis Child 1977;52:219-22
  9. Peevy KJ, Wiseman HJ. AB0 hemolytic disease of the newborn: Evaluation of management and identification of racial and antigenic factors. Pediatrics 1978;61:475-8
  10. Bhutani VK, Johnson LH, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near term newborns. Pediatrics 1999;103:6-14
  11. Madam A, MacMonon JR, Stevenson DK. Neonatal hyperbilirubinemia. In: Taeusch HW, Ballard RA, Gleason CA, (eds). Avery’s Diseases of the Newborn, 8th ed. Philadelphia, PA: WB Saunders, 2005:1226-50
  12. Bhutani VK, Johnson LH. Diagnosis and management of hyperbilirubinemia in the term neonate for a safer first week. Pediatr Clin North Am 2004;51:843-61
  13. Basu S, Kaur R, Kaur G. Hemolytic disease of the fetus and newborn: Current trends and perspectives. Asian J Transfus Sci 2011;5:3-7
  14. Dufour DR, Monoghan WP. AB0 haemolytic disease of the newbor